BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17467061)

  • 1. Neopterin levels and dexamethasone suppression test in obsessive-compulsive disorder.
    Kuloğlu M; Atmaca M; Onal S; Geçici O; Bulut V; Tezcan E
    Psychiatry Res; 2007 Jun; 151(3):265-70. PubMed ID: 17467061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum leptin levels in obsessive-compulsive disorder.
    Atmaca M; Tezcan E; Kuloglu M; Ustundag B
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):189-93. PubMed ID: 15823166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder.
    Atmaca M; Kuloglu M; Tezcan E; Onal S; Ustundag B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):161-5. PubMed ID: 12242576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obsessive-compulsive disorder, depression, and the dexamethasone suppression test.
    Jenike MA; Baer L; Brotman AW; Goff DC; Minichiello WE; Regan NJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):182-4. PubMed ID: 3597805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired procedural learning in obsessive-compulsive disorder and Parkinson's disease, but not in major depressive disorder.
    Joel D; Zohar O; Afek M; Hermesh H; Lerner L; Kuperman R; Gross-Isseroff R; Weizman A; Inzelberg R
    Behav Brain Res; 2005 Feb; 157(2):253-63. PubMed ID: 15639176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin and leptin levels in patients with obsessive-compulsive disorder.
    Emül HM; Serteser M; Kurt E; Ozbulut O; Guler O; Gecici O
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1270-4. PubMed ID: 17597276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-brain antibodies in adult patients with obsessive-compulsive disorder.
    Maina G; Albert U; Bogetto F; Borghese C; Berro AC; Mutani R; Rossi F; Vigliani MC
    J Affect Disord; 2009 Aug; 116(3):192-200. PubMed ID: 19138800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncomplicated and complicated obsessive-compulsive disorder: an exploratory study from India.
    Kalra H; Trivedi JK; Dalal PK; Sinha PK; Allet JL
    Compr Psychiatry; 2008; 49(1):51-4. PubMed ID: 18063041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone suppression test in primary depression: significance of family history and psychosis.
    Rudorfer MV; Hwu HG; Clayton PJ
    Biol Psychiatry; 1982 Jan; 17(1):41-8. PubMed ID: 7059638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive-compulsive disorder in callers to the Anxiety Disorders Association of America.
    Hidalgo RB; Ross J; Davidson JR
    Ann Clin Psychiatry; 2006; 18(3):157-62. PubMed ID: 16923653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar obsessive-compulsive disorder and personality disorders.
    Maina G; Albert U; Pessina E; Bogetto F
    Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empathy and symptoms dimensions of patients with obsessive-compulsive disorder.
    Fontenelle LF; Soares ID; Miele F; Borges MC; Prazeres AM; Rangé BP; Moll J
    J Psychiatr Res; 2009 Jan; 43(4):455-63. PubMed ID: 18614180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtyping obsessive-compulsive disorder: clinical and immunological findings in child and adult onset.
    Morer A; Viñas O; Lázaro L; Calvo R; Andrés S; Bosch J; Gastó C; Massana J; Castro J
    J Psychiatr Res; 2006 Apr; 40(3):207-13. PubMed ID: 16019031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF 5-HIAA and DST non-suppression--orthogonal biologic risk factors for suicide in male mood disorder inpatients.
    Jokinen J; Nordström AL; Nordström P
    Psychiatry Res; 2009 Jan; 165(1-2):96-102. PubMed ID: 19062105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom overlap between autism spectrum disorder, generalized social anxiety disorder and obsessive-compulsive disorder in adults: a preliminary case-controlled study.
    Cath DC; Ran N; Smit JH; van Balkom AJ; Comijs HC
    Psychopathology; 2008; 41(2):101-10. PubMed ID: 18033980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of patients with schizophrenia, obsessive-compulsive disorder, and schizophrenia with accompanying obsessive-compulsive symptoms].
    Güleç G; Güneş E; Yenilmez C
    Turk Psikiyatri Derg; 2008; 19(3):247-56. PubMed ID: 18791877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder.
    Remijnse PL; Nielen MM; van Balkom AJ; Hendriks GJ; Hoogendijk WJ; Uylings HB; Veltman DJ
    Psychol Med; 2009 Sep; 39(9):1503-18. PubMed ID: 19171077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the phenotypic expression of obsessive-compulsive disorder: an exploratory study from Brazil.
    Torresan RC; Ramos-Cerqueira AT; de Mathis MA; Diniz JB; Ferrão YA; Miguel EC; Torres AR
    Compr Psychiatry; 2009; 50(1):63-9. PubMed ID: 19059516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder.
    Gustafsson PE; Gustafsson PA; Ivarsson T; Nelson N
    Neuropsychobiology; 2008; 57(1-2):14-21. PubMed ID: 18424906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive-compulsive disorder and migraine with medication-overuse headache.
    Cupini LM; De Murtas M; Costa C; Mancini M; Eusebi P; Sarchielli P; Calabresi P
    Headache; 2009 Jul; 49(7):1005-13. PubMed ID: 19496831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.